全文获取类型
收费全文 | 13615篇 |
免费 | 837篇 |
国内免费 | 94篇 |
专业分类
耳鼻咽喉 | 127篇 |
儿科学 | 388篇 |
妇产科学 | 379篇 |
基础医学 | 1832篇 |
口腔科学 | 246篇 |
临床医学 | 1078篇 |
内科学 | 3346篇 |
皮肤病学 | 231篇 |
神经病学 | 1780篇 |
特种医学 | 573篇 |
外科学 | 1495篇 |
综合类 | 26篇 |
一般理论 | 3篇 |
预防医学 | 648篇 |
眼科学 | 192篇 |
药学 | 998篇 |
中国医学 | 16篇 |
肿瘤学 | 1188篇 |
出版年
2024年 | 23篇 |
2023年 | 171篇 |
2022年 | 279篇 |
2021年 | 558篇 |
2020年 | 316篇 |
2019年 | 434篇 |
2018年 | 484篇 |
2017年 | 376篇 |
2016年 | 423篇 |
2015年 | 451篇 |
2014年 | 639篇 |
2013年 | 769篇 |
2012年 | 1008篇 |
2011年 | 1061篇 |
2010年 | 616篇 |
2009年 | 532篇 |
2008年 | 774篇 |
2007年 | 759篇 |
2006年 | 746篇 |
2005年 | 686篇 |
2004年 | 531篇 |
2003年 | 441篇 |
2002年 | 420篇 |
2001年 | 183篇 |
2000年 | 209篇 |
1999年 | 180篇 |
1998年 | 95篇 |
1997年 | 74篇 |
1996年 | 61篇 |
1995年 | 49篇 |
1994年 | 51篇 |
1993年 | 37篇 |
1992年 | 111篇 |
1991年 | 125篇 |
1990年 | 113篇 |
1989年 | 94篇 |
1988年 | 101篇 |
1987年 | 89篇 |
1986年 | 73篇 |
1985年 | 60篇 |
1984年 | 38篇 |
1983年 | 39篇 |
1982年 | 21篇 |
1981年 | 19篇 |
1980年 | 18篇 |
1979年 | 28篇 |
1978年 | 17篇 |
1974年 | 18篇 |
1973年 | 18篇 |
1970年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
Gadducci A Carnino F Chiara S Brunetti I Tanganelli L Romanini A Bruzzone M Conte PF 《Gynecologic oncology》2000,76(2):157-162
Intraperitoneal chemotherapy has a strong biological and pharmacological rationale in the treatment of ovarian cancer. From 1989 to 1996 the present study included 113 patients with FIGO stage II-IV ovarian cancer with residual disease less than 2 cm who were randomly allocated to receive 50 mg/m(2) intraperitoneal cisplatin (CDDP) plus 60 mg/m(2) intravenous epidoxorubicin (EPIDOX) and 600 mg/m(2) intravenous cyclophosphamide (CTX) (ipPEC arm) or 50 mg/m(2) intravenous CDDP plus 60 mg/m(2) intravenous EPIDOX and 600 mg/m(2) intravenous CTX (ivPEC arm). Chemotherapy was repeated every 4 weeks for six cycles. Treatment protocol was changed in 22 patients, 2 from the iv arm (who received single-agent carboplatin) and 20 from the ip arm (who were crossed to systemic chemotherapy, ivPEC, or single-agent carboplatin). At the end of chemotherapy, a second-look was performed in 33 of the 54 patients from the ip arm and in 34 of the 57 patients from the systemic arm. The pathologic complete response rate was 41% of all entered patients and 69% of patients submitted to second-look. No significant difference in pathologic response rate as well as in hematologic and nonhematologic toxicities was seen between the two arms. Up to September 1998, 72 patients showed a disease recurrence (33 treated with ipPEC and 39 treated with ivPEC), 55 died (22 ipPEC and 30 ivPEC), and 10 were lost to follow-up (6 ipPEC and 4 ivPEC). Median progression-free survival was 42 and 25 months for ipPEC and ivPEC, respectively (p = 0.13). Median overall survival was 67 and 51 months for ipPEC and ivPEC, respectively (p = 0.14). In conclusion, besides confirming that intraperitoneal chemotherapy is feasible with acceptable toxicity but with poor compliance in community hospitals, this trial showed that intraperitoneal CDDP compared with intravenous CDDP in combination with EPIDOX and CTX obtained a slight (not significant) improvement in progression-free survival and overall survival of optimally cytoreduced advanced ovarian cancer patients. 相似文献
992.
M Scaturro I Dell'eva F Helfer M L Ricci 《Infection control and hospital epidemiology》2007,28(9):1089-1092
In 2004, an outbreak of legionnaires disease occurred in a hospital in northern Italy with a water system that had been disinfected multiple times since 1990 and equipped with a continuous disinfecting system. Molecular typing linked the outbreak to contamination of the hospital water system and demonstrated the persistence of a predominant strain of Legionella pneumophila for 15 years. 相似文献
993.
Busto G Corvò R Ricci I Sanguineti G Benasso M 《Expert review of anticancer therapy》2001,1(1):111-115
Head and neck squamous cell cancer is the sixth most common cancer worldwide. Surgical management is effective as a single modality only for early-stage cancers (30% of patients). Making progress in this cancer is of vital interest. The standard treatment for advanced disease is chemoradiotherapy, with the goal of palliation of symptoms and prolongation of life. Response rates to even the best of regimens are approximately 30-40%, with the median survival period of approximately 6 months. Various approaches to treatment of recurrent disease are under investigation, including new drugs or combinations of drugs, with radiotherapy. 相似文献
994.
Eruptive pseudoangiomatosis 总被引:1,自引:0,他引:1
Neri I Patrizi A Guerrini V Ricci G Cevenini R 《The British journal of dermatology》2000,143(2):435-438
Eruptive pseudoangiomatosis (EPA) is a rare, benign, spontaneously regressing childhood exanthem. The term was recently coined by Prose et al.1 to describe a dermatosis characterized by the sudden onset of a few to several bright red angioma-like papules with a different histopathology from the true angiomas. We describe three patients with the typical lesions of EPA but with some peculiar features not previously described. We discuss the suspected viral aetiology of EPA, and hypothesize a multifactorial aetiopathogenesis. 相似文献
995.
Claudia Massarotti Giulia Gentile Chiara Ferreccio Paola Scaruffi Valentino Remorgida Paola Anserini 《Gynecological endocrinology》2019,35(6):485-489
AbstractThis study aims to evaluate levels of anxiety and depression in women, correlated with infertility per se and with infertility treatments, highlighting predictors of higher levels of distress. Two validated standardized questionnaires, the Hospital Anxiety and Depression Scale (HADS) and the Fertility Quality of Life (FertiQoL), were administered to 89 women both before their first cycle of infertility treatment and again at the end of the ovarian stimulation for in vitro fertilization (IVF). Women's levels of anxiety were significantly higher before the treatment than during the treatment itself. Stratifying the women in three groups based on principal cause of infertility (male infertility, female infertility, or both male and female), we found significantly higher levels of anxiety and general distress in patients under treatment for female infertility. Higher anxiety levels in our sample before the treatment are probably an effect of not knowing what they are expected to do to solve their problem. Moreover, when the cause of infertility is exclusively female, women experience higher levels of anxiety and general distress both before and during the treatment, probably correlated to a sense of guilt. These data help the treating physician to better counsel patients and to provide a more focused psychological support. 相似文献
996.
L Crinò G V Scagliotti S Ricci F De Marinis M Rinaldi C Gridelli A Ceribelli R Bianco M Marangolo F Di Costanzo M Sassi S Barni A Ravaioli V Adamo L Portalone G Cruciani A Masotti G Ferrara F Gozzelino M Tonato 《Journal of clinical oncology》1999,17(11):3522-3530
PURPOSE: To compare gemcitabine and cisplatin (GC) with mitomycin, ifosfamide, and cisplatin (MIC) chemotherapy in patients with stage IIIB (limited to T4 for pleural effusion and N3 for supraclavicular lymph nodes) or stage IV non-small-cell lung cancer (NSCLC). The end points were the evaluation of quality of life (QoL), response rates, survival, and toxicity. PATIENTS AND METHODS: Three hundred seven patients were randomized to receive either gemcitabine 1,000 mg/m(2) on days 1, 8, and 15 plus cisplatin 100 mg/m(2) on day 2, every 28 days, or mitomycin 6 mg/m(2), ifosfamide 3,000 mg/m(2), and mesna on day 1 plus cisplatin 100 mg/m(2) on day 2, every 28 days. The whole-blood cell count was repeated on day 1 in both arms and weekly in the GC arm before each gemcitabine administration. RESULTS: No major differences in changes in QoL were observed between the two treatment arms. The objective response rate was 38% in the GC arm compared with 26% in the MIC arm (P =.029). The median survival time was 8.6 months in the GC arm and 9.6 months in the MIC arm (P =.877, log-rank test). Grade 3 and 4 thrombocytopenia was significantly worse in the GC arm (64% v 28%, P <.001), whereas grade 3 and 4 alopecia was reported more commonly in the MIC arm (39% v 12%, P <. 001). CONCLUSION: We report an increased response rate without changes in QoL and a similar overall survival, time to progression, and time to treatment failure for the GC when compared with the MIC regimen in the treatment of advanced NSCLC. 相似文献
997.
Sylvie Ménard Patrizia Casalini Gorana Tomasic Silvana Pilotti Natale Cascinelli Rosaria Bufalino Franco Perrone Chiara Longhi Franco Rilke M. Ines Colnaghi 《Breast cancer research and treatment》1999,55(2):167-175
Many different pathological and biological variables which characterize breast carcinomas have been found to be associated. The aim of this work was to analyze the complex relationship among these parameters. The pathologic, biologic, and clinical characteristics of a series of primary breast carcinomas from 676 patients were retrospectively investigated. Multiple correspondence analysis of 13 factors revealed clustering of eight pathobiologic variables, that is histologic grade, necrosis, lymphoid infiltration, number of mitoses, cerbB2 overexpression, p53, progesterone receptor, and bcl2 expression. An index for each tumor calculated on the basis of these eight factors served to distinguish two different tumor phenotypes, designated A and B. Phenotype A is represented by tumors sharing most of the biologic features of normal breast tissues: indeed, these tumors are characterized by a relatively high degree of differentiation, low proliferation, no necrosis or leukocyte infiltration, and no gene alterations. By contrast, phenotype B is quite divergent from the normal tissue because of its poor differentiation, high proliferation, frequent gene alterations and evidence of a host immune reaction. As regards the disease progression, these two subsets showed marked differences: phenotype A tumors had a low recurrence rate per year that remained constant over time and affected more frequently elderly patients, whereas group B tumors showed high aggressivity in the first years after surgery followed by a low longterm recurrence rate and were more frequently seen in younger patients. These data suggest that breast carcinoma consists of two different subsets that can be identified on the basis of pathobiologic features. 相似文献
998.
Cleavage and relocation of the tyrosine kinase P59FYN during Fas-mediated apoptosis in T lymphocytes. 总被引:1,自引:0,他引:1
J E Ricci L Maulon F Luciano S Guerin A Livolsi B Mari J P Breittmayer J F Peyron P Auberger 《Oncogene》1999,18(27):3963-3969
Ligation of Fas with its natural ligand or with anti-Fas antibodies induces an apoptotic program in Fas sensitive cells. We report here the identification of the tyrosine kinase p59Fyn as a substrate for CPP32-like proteinases and more particularly caspase 3 during Fas-mediated apoptosis in Jurkat T cells. Inhibition of CPP32-like proteinases by Ac-Asp-Glu-Val-Asp-aldehyde but not by Ac-Tyr-Val-Ala-Asp-aldehyde prevents CPP32, PARP and p59Fyn cleavage indicating that CPP32 or CPP32-like proteinases are responsible for the cleavage of p59Fyn. Cleavage occurs in the N-terminal domain of p59Fyn between Asp19 and Gly20 and is accompanied by relocation of an active p57Fyn kinase to cytoplasm of Fas-stimulated Jurkat cells as judged by both biochemical and confocal microscopy experiments. Thus, p59Fyn relocation and activity may play an important role during Fas-mediated cell death in human T lymphocytes. 相似文献
999.
1000.
Wolfgang Hild Klaus Pollinger Andrea Caporale Chiara Cabrele Max Keller Nicola Pluym Armin Buschauer Reinhard Rachel Joerg Tessmar Miriam Breunig Achim Goepferich 《Proceedings of the National Academy of Sciences of the United States of America》2010,107(23):10667-10672
More selective interactions of nanoparticles with cells would substantially increase their potential for diagnostic and therapeutic applications. Thus, it would not only be highly desirable that nanoparticles can be addressed to any cell with high target specificity and affinity, but that we could unequivocally define whether they rest immobilized on the cell surface as a diagnostic tag, or if they are internalized to serve as a delivery vehicle for drugs. To date no class of targets is known that would allow direction of nanoparticle interactions with cells alternatively into one of these mutually exclusive events. Using MCF-7 breast cancer cells expressing the human Y1-receptor, we demonstrate that G protein-coupled receptors provide us with this option. We show that quantum dots carrying a surface-immobilized antagonist remain with nanomolar affinity on the cell surface, and particles carrying an agonist are internalized upon receptor binding. The receptor functions like a logic “and-gate” that grants cell access only to those particles that carry a receptor ligand “and” where the ligand is an agonist. We found that agonist- and antagonist-modified nanoparticles bind to several receptor molecules at a time. This multiligand binding leads to five orders of magnitude increased-receptor affinities, compared with free ligand, in displacement studies. More than 800 G protein-coupled receptors in humans provide us with the paramount advantage that targeting of a plethora of cells is possible, and that switching from cell recognition to cell uptake is simply a matter of nanoparticle surface modification with the appropriate choice of ligand type. 相似文献